Literature DB >> 30488951

Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Moriah Gildart1, Michael S Kapiloff2, Kimberly L Dodge-Kafka1.   

Abstract

The ubiquitous Ca2+ /calmodulin-dependent phosphatase calcineurin is a key regulator of pathological cardiac hypertrophy whose therapeutic targeting in heart disease has been elusive due to its role in other essential biological processes. Calcineurin is targeted to diverse intracellular compartments by association with scaffold proteins, including by multivalent A-kinase anchoring proteins (AKAPs) that bind protein kinase A and other important signalling enzymes determining cardiac myocyte function and phenotype. Calcineurin anchoring by AKAPs confers specificity to calcineurin function in the cardiac myocyte. Targeting of calcineurin 'signalosomes' may provide a rationale for inhibiting the phosphatase in disease.
© 2018 The Authors. The Journal of Physiology © 2018 The Physiological Society.

Entities:  

Keywords:  AKAP; calcineurin; heart; hypertrophy

Mesh:

Substances:

Year:  2018        PMID: 30488951      PMCID: PMC7586300          DOI: 10.1113/JP276756

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  103 in total

Review 1.  Inhibitors of the calcineurin/NFAT pathway.

Authors:  Sara Martínez-Martínez; Juan Miguel Redondo
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

2.  Cypher/ZASP is a novel A-kinase anchoring protein.

Authors:  Changsong Lin; Xiaogang Guo; Stephan Lange; Jie Liu; Kunfu Ouyang; Xiang Yin; Liujun Jiang; Yibo Cai; Yongxin Mu; Farah Sheikh; Sheng Ye; Ju Chen; Yuehai Ke; Hongqiang Cheng
Journal:  J Biol Chem       Date:  2013-08-31       Impact factor: 5.157

3.  Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth.

Authors:  Qinghang Liu; Benjamin J Wilkins; Yong J Lee; Hidenori Ichijo; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

4.  Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.

Authors:  Lei Li; Jing Li; Benjamin M Drum; Yi Chen; Haifeng Yin; Xiaoyun Guo; Stephen W Luckey; Merle L Gilbert; G Stanley McKnight; John D Scott; L Fernando Santana; Qinghang Liu
Journal:  Cardiovasc Res       Date:  2016-11-17       Impact factor: 10.787

5.  Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.

Authors:  Benjamin J Wilkins; Yan-Shan Dai; Orlando F Bueno; Stephanie A Parsons; Jian Xu; David M Plank; Fred Jones; Thomas R Kimball; Jeffery D Molkentin
Journal:  Circ Res       Date:  2003-12-01       Impact factor: 17.367

6.  Loss of calcineurin Aalpha alters keratinocyte survival and differentiation.

Authors:  Juan A Pena; Jacqueline L Losi-Sasaki; Jennifer L Gooch
Journal:  J Invest Dermatol       Date:  2010-01       Impact factor: 8.551

Review 7.  An emerging role for calcineurin Aalpha in the development and function of the kidney.

Authors:  Jennifer L Gooch
Journal:  Am J Physiol Renal Physiol       Date:  2006-04

8.  Carvedilol reverses cardiac insufficiency in AKAP5 knockout mice by normalizing the activities of calcineurin and CaMKII.

Authors:  Xin Li; Shannon M Matta; Ryan D Sullivan; Suleiman W Bahouth
Journal:  Cardiovasc Res       Date:  2014-09-15       Impact factor: 10.787

9.  Calcineurin A-β is required for hypertrophy but not matrix expansion in the diabetic kidney.

Authors:  Ramesh N Reddy; Taylor L Knotts; Brian R Roberts; Jeffery D Molkentin; S Russ Price; Jennifer L Gooch
Journal:  J Cell Mol Med       Date:  2011-02       Impact factor: 5.310

10.  The AKAP Cypher/Zasp contributes to β-adrenergic/PKA stimulation of cardiac CaV1.2 calcium channels.

Authors:  Haijie Yu; Can Yuan; Ruth E Westenbroek; William A Catterall
Journal:  J Gen Physiol       Date:  2018-05-09       Impact factor: 4.086

View more
  2 in total

Review 1.  Calcineurin in the heart: New horizons for an old friend.

Authors:  Malay Chaklader; Beverly A Rothermel
Journal:  Cell Signal       Date:  2021-08-25       Impact factor: 4.315

2.  AKAP79 enables calcineurin to directly suppress protein kinase A activity.

Authors:  Timothy W Church; Parul Tewatia; Saad Hannan; João Antunes; Olivia Eriksson; Trevor G Smart; Jeanette Hellgren Kotaleski; Matthew G Gold
Journal:  Elife       Date:  2021-10-06       Impact factor: 8.140

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.